Aaron Schacht

Aaron Schacht Email and Phone Number

Independent Director @ Redux Bio
Indianapolis, IN, US
Aaron Schacht's Location
Greater Indianapolis, United States, United States
About Aaron Schacht

30 years transforming projects, portfolios and companies, the next 20 years transforming an industry.With over 30 years of experience in the life sciences industry, I am a seasoned executive leader and entrepreneur who is passionate about driving innovation and creating value for patients, customers, and stakeholders. As the CEO and Board Director of BiomEdit, a biotechnology company focused on animal health product innovation leveraging the science of the microbiome and synthetic biology, I lead a team of talented scientists and business professionals who are committed to developing novel solutions for some of the most pressing challenges in animal health and welfare.My core competencies include drug discovery and development, R&D strategy and transformation, business development and licensing, mergers and acquisitions, venture capital and private equity, and external R&D and open innovation. I have a proven track record of delivering results and achieving growth, having led or been involved in envisioning, forming, funding, and starting up several venture-funded companies, as well as executing nearly $8.5B in M&A transactions with Elanco Animal Health. I also serve on the boards of several for-profit and non-profit organizations in the life sciences and biotechnology sectors, where I leverage my expertise and network to support their missions and goals.

Aaron Schacht's Current Company Details
Redux Bio

Redux Bio

View
Independent Director
Indianapolis, IN, US
Website:
reduxbio.com
Employees:
7
Aaron Schacht Work Experience Details
  • Redux Bio
    Independent Director
    Redux Bio
    Indianapolis, In, Us
  • Biomedit
    Chief Executive Officer And Board Director
    Biomedit Apr 2022 - Present
    Fishers, Indiana, Us
    BiomEdit is a biotechnology company focused on animal health product innovation leveraging the science of the microbiome and synthetic biology to address significant challenges in animal health.
  • Gallant Therapeutics
    Member Board Of Directors
    Gallant Therapeutics Feb 2024 - Present
    San Diego, Ca, Us
  • Redux Bio
    Independent Director
    Redux Bio Mar 2022 - Present
    San Francisco, Ca, Us
  • Indiana Biosciences Research Institute
    Board Member
    Indiana Biosciences Research Institute Jan 2021 - Present
    Indianapolis, Indiana, Us
  • Agrinovus Indiana
    Board Member & Chairman Emeritus
    Agrinovus Indiana Jan 2016 - Dec 2023
    Indianapolis, Indiana, Us
  • Scout Bio
    Non Executive Director
    Scout Bio Feb 2022 - Nov 2023
    Philadelphia, Pa, Us
  • Mbrd Service Company, Llc
    President/Ceo
    Mbrd Service Company, Llc Dec 2021 - Apr 2022
    MBRD Service Company LLC was originally the entity established with a primary purpose to facilitate the carveout of Elanco's leading edge microbiome R&D platform and pipeline. Established in January of 2022 with the team of expert scientists, product developers, regulatory experts and business leaders from Elanco. MBRD focuses on providing MicroBiome-related R&D services. MBRD successfully enabled the carve out and financing transaction for BiomEdit.
  • Elanco
    Executive Vice President - Elanco Animal Health
    Elanco Oct 2021 - Dec 2021
    Greenfield, In, Us
    Led strategic initiative to carve out Elanco's Microbiome R&D platform into privately funded venture.Retired from Elanco
  • Elanco
    Executive Vice President - Innovation, Regulatory & Business Development
    Elanco Sep 2018 - Oct 2021
    Greenfield, In, Us
    Aaron Schacht served as executive vice president, Innovation, Regulatory, and Business Development at Elanco. In this role, he oversaw global R&D, regulatory, business development and nutritional health. Responsible for all internal and external innovation, regulatory affairs, business development & licensing, mergers & acquisitions, and transformational strategic alliances. Led the following acquisitions: Aratana Therapeutics, Prevtec Microbia, Bayer Animal Health, Kindred Biosciences. Transformed Elanco R&D through multiple acquisition integrations, IPO of Elanco, Separation from Lilly and acquisition and integration of Bayer Animal Health.
  • Elanco
    Vice President - Global R&D/Regulatory/Bus Dev’T/Nutritional Health
    Elanco Oct 2015 - Sep 2018
    Greenfield, In, Us
    Responsible for discovery research, development, regulatory, external innovation, business development and Elanco Nutritional Health.
  • Eli Lilly And Company
    Global Brand Development Leader - Pain - Lilly Biomedicines
    Eli Lilly And Company Feb 2014 - Sep 2015
    Indianapolis, Indiana, Us
    Lead Product Development/Commercialization for LY2951742 - a novel CGRP Neutralizing Antibody which launched as Emgality in 2018
  • Eli Lilly And Company
    Sr. Director - Product Development Strategy, Operations & Business Dev'T - Lilly Biomedicines
    Eli Lilly And Company Jan 2012 - Oct 2014
    Indianapolis, Indiana, Us
    Strategy, Development Operations, Portfolio Management and Business Development for Lilly BioMedicines Business Unit - Lilly's largest and most comprehensive business unit.Implemented improved TA Strategies, Pipeline/Portfolio Management, Product Development Strategy & Operations, and Business Development Strategies and Processes.
  • Eli Lilly And Company
    Executive Director & Chief Operating Officer - Global External R&D
    Eli Lilly And Company Oct 2008 - Dec 2011
    Indianapolis, Indiana, Us
    Accomplishments:• Lead and oversaw strategy and operations of Lilly’s Global External R&D group• Vanthys: Launched and managed Novel Early Development Joint Venture in India, later acquired by JV partner Jubilant• Geographic Surveillance efforts in India and Japan• Developed and Launch Lilly Mirror Funds/Built Lilly Mirror Portfolio, resulting in Artaeus, Dekkun, Anexon, Apofore, Tensha, GITR.
  • Eli Lilly And Company
    Executive Director - R&D Strategy, Portfolio And Project Management
    Eli Lilly And Company Sep 2005 - Sep 2008
    Indianapolis, Indiana, Us
    Executive leader for all efforts in Pipeline/Portfolio Management, Enterprise Resource/Financial Planning and Capacity Analysis, Long Range R&D Strategy and Plan, and Evolution of R&D Project Management capabilities, tools and organization.
  • Eli Lilly And Company
    Director, Lrl Strategy
    Eli Lilly And Company Jun 2004 - Aug 2005
    Indianapolis, Indiana, Us
    Led strategy setting and strategic planning for Lilly Research Laboratories to optimize R&D pipeline.
  • Eli Lilly And Company
    Director - Elilly Innovation Center
    Eli Lilly And Company Nov 2002 - May 2004
    Indianapolis, Indiana, Us
    New Venture Creation & Development, New Business Incubation, Innovation Management. Incubated following start-up companies: Indigo Biosystems, Collaborative Drug Discovery, Coalesix, and Maaguzi
  • Artesian Therapeutics
    Ceo/Co-Founder
    Artesian Therapeutics Feb 2002 - Nov 2002
    Founder and founding CEO for Artesian Therapeutics, a cardiovascular small molecule drug development company focused on dual pharmacophore strategies for developing novel therapies for congestive heart failure. Artesian later acquired by Cardiome Pharma.
  • Eli Lilly And Company
    Managing Director - Lilly University
    Eli Lilly And Company Jun 2001 - Feb 2002
    Indianapolis, Indiana, Us
    Interim leadership for Global Training and Dev't Organization. Developed and launched enterprise e-Learning platform.
  • Eli Lilly And Company
    Director - Knowledge Management
    Eli Lilly And Company Jan 2000 - May 2001
    Indianapolis, Indiana, Us
    Founding leader for Lilly Knowledge Management program with specific focus on implementation of enterprise IT capabilities across Lilly for enterprise portal, enterprise content management, exploitation of internet tools.Co-conceived Innocentive with Alph Bingham.
  • Eli Lilly And Company
    Manager - Discovery Strategy/Productivity
    Eli Lilly And Company Jan 1997 - Dec 1999
    Indianapolis, Indiana, Us
    Led Drug Discovery strategy, portfolio management and transformation initiatives to enhance Lilly Research Laboratories discovery output, producing and sustaining a tripling of drug candidate selection output over 3 year period.
  • Eli Lilly And Company
    Productivity Projects Associate
    Eli Lilly And Company Sep 1995 - Dec 1996
    Indianapolis, Indiana, Us
    Initiated, led and implemented cross-functional discovery process improvement initiatives in Lilly Research Laboratories.
  • Eli Lilly And Company
    Medicinal Chemist
    Eli Lilly And Company Jul 1990 - Aug 1995
    Indianapolis, Indiana, Us
    Medicinal Chemist working in the area of Oral Anticoagulants. Co-Inventor on 17 patents. Co-inventor on patent for Exanta.
  • The Dow Chemical Company
    Co-Op Education
    The Dow Chemical Company Aug 1986 - Sep 1989
    Midland, Michigan, Us
    Co-Op Education Employee for Dow Chemical. Worked in Saran R&D, Design Thermoplastics Research, Versene/Chelants Technical Service

Aaron Schacht Skills

Pharmaceutical Industry Drug Discovery Drug Development Strategy Lifesciences Start Ups Biotechnology R&d Cross Functional Team Leadership Life Sciences Clinical Development Clinical Trials Biopharmaceuticals Technology Transfer Business Development Oncology Regulatory Affairs Clinical Research Knowledge Management Product Development Biochemistry Commercialization Fda Pharmaceutics Cro Molecular Biology Regulatory Submissions Program Management Pharmacology Research And Development Validation Gmp Science Medicinal Chemistry Informatics Medical Devices Diabetes U.s. Food And Drug Administration

Aaron Schacht Education Details

  • University Of Illinois Urbana-Champaign
    University Of Illinois Urbana-Champaign
    Chemistry
  • Pecatonica High School
    Pecatonica High School
    College Prep

Frequently Asked Questions about Aaron Schacht

What company does Aaron Schacht work for?

Aaron Schacht works for Redux Bio

What is Aaron Schacht's role at the current company?

Aaron Schacht's current role is Independent Director.

What is Aaron Schacht's email address?

Aaron Schacht's email address is sc****@****nco.com

What is Aaron Schacht's direct phone number?

Aaron Schacht's direct phone number is +131773*****

What schools did Aaron Schacht attend?

Aaron Schacht attended University Of Illinois Urbana-Champaign, Pecatonica High School.

What skills is Aaron Schacht known for?

Aaron Schacht has skills like Pharmaceutical Industry, Drug Discovery, Drug Development, Strategy, Lifesciences, Start Ups, Biotechnology, R&d, Cross Functional Team Leadership, Life Sciences, Clinical Development, Clinical Trials.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.